Company Filing History:
Years Active: 1994-1999
Title: Thomas Munk Plum: Innovator in Infusion Technology
Introduction
Thomas Munk Plum is a notable inventor based in Skodsborg, Denmark. He has made significant contributions to the field of infusion technology, holding a total of 5 patents. His work focuses on developing innovative solutions that enhance the efficiency and effectiveness of infusion devices.
Latest Patents
One of his latest patents is an advanced infuser designed for infusing liquids from a reservoir. This device comprises a durable part that forms a housing and a disposable part containing the liquid reservoir and an energy reservoir for energizing the pumping function. The infuser is engineered to ensure that all liquid-contacting elements are contained within the disposable part, which is coupled with the durable part through mating coupling means. Additionally, the infuser features a controlling unit located in the electronic compartment of the durable part, equipped with a socket for a plug that carries infusion data. This innovative design allows for a graphic representation of the information to be displayed in relation to the data shown on the device's display.
Career Highlights
Thomas Munk Plum is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role involves leveraging his expertise in infusion technology to develop cutting-edge medical devices that improve patient care. His contributions have been instrumental in advancing the capabilities of infusion systems.
Collaborations
Throughout his career, Thomas has collaborated with several talented individuals, including Henrik-Egesborg Hansen and Henrik Ege. These partnerships have fostered a creative environment that encourages innovation and the development of new technologies.
Conclusion
Thomas Munk Plum is a distinguished inventor whose work in infusion technology has led to significant advancements in medical devices. His innovative designs and collaborative efforts continue to shape the future of healthcare.